Medical Devices Investors & VC Firms in United States
1104 firms in this list, with a median first check of $500K. 275 of them lead rounds. Generated from verified public data and updated continuously.
Cowtown Angels
Fort WorthPre-Seed–Series A
12 people
Dellin Investments
PhiladelphiaPre-Seed–Growth
7 people
Revelation Partners
SausalitoGrowth–Late Stage$5M – $50M
15 people
Waterline Ventures
CambridgeSeed–Growth
15 people
MedTech Venture Partners
Menlo ParkSeed–Series A
29 people
LYFE Capital
Menlo ParkSeed–Late Stage
22 people
Dimension Capital
San FranciscoSeed–Growth$1M – $10M
18 people
MEDA Angels
ArlingtonSeed–Series A$130K – $350K
18 people
Remiges Ventures, Inc.
SeattleSeed
21 people
Solas BioVentures
ChattanoogaSeed–Series B
17 people
Forepont Capital Partners
New YorkPre-Seed–Series A
24 people
Whistler Capital Partners
NashvilleGrowth
23 people
Callais Capital Management
New OrleansSeed–Series A
15 people
Pivotal Life Sciences
San FranciscoPre-Seed–Late Stage
14 people
WRF Capital
SeattlePre-Seed–Series A$100K – $2M
20 people
Eckuity
CypressGrowth
24 people
Breakout Ventures
San FranciscoSeed–Series A$500K – $6M
14 people
Standard Capital
San FranciscoSeries A
8 people
Tullis Health Investors
Palm Beach GardensSeries A–Late Stage$500K – $10M
17 people
Kilonova Capital
San FranciscoGrowth–Late Stage$25M – $150M
30 people
LOUD Capital
ColumbusSeed–Growth
25 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
Phoenix Venture Partners
San MateoSeed–Series A$100K – $3M
10 people
Monograph Capital Partners
Fort WorthSeed–Growth
21 people
Related lists
Investors & VC Firms in North America (13286)Investors & VC Firms in United States (12284)Investors & VC Firms in Europe (6052)AI & Machine Learning Investors & VC Firms (5303)Investors & VC Firms in Global (5278)Fintech Investors & VC Firms (5112)Healthtech Investors & VC Firms (4639)SaaS Investors & VC Firms (4498)Enterprise Software Investors & VC Firms (4394)Crypto & Web3 Investors & VC Firms (4130)
Data sourced from public filings and firms' own websites — see our methodology.







































































































